Current Cancer Drug Targets
Volume 19, 11 Issues, 2019
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Ranking and Category
-
135th of 229 in
Oncology
Most Accessed Articles
Polyploid Giant Cancer Cells (PGCCs): The Evil Roots of Cancer
, 2019; 19(5): 360-367.Junsong Chen, Na Niu, Jing Zhang, Lisha Qi, Weiwei Shen, Krishna Vanaja Donkena, Zhenqing Feng and Jinsong Liu*
DOI: 10.2174/1568009618666180703154233
Toxicology of Trastuzumab: An Insight into Mechanisms of Cardiotoxicity
, 2019; 19(5): 400-407.Jie An* and M. Saeed Sheikh*
DOI: 10.2174/1568009618666171129222159
The RNA Binding Protein HuR: a Promising Drug Target for Anticancer Therapy
, 2019; 19(5): 382-399.Mingxia Wu, Christy W.S. Tong, Wei Yan, Kenneth K.W. To* and William C.S. Cho*
DOI: 10.2174/1568009618666181031145953
Combination Therapies Using Metformin and/or Valproic Acid in Prostate Cancer: Possible Mechanistic Interactions
, 2019; 19(5): 368-381.Linh N.K. Tran*, Ganessan Kichenadasse and Pamela J. Sykes
DOI: 10.2174/1568009618666180724111604
In Silico Structure Modeling and Molecular Docking Analysis of Phosphoribosyl Pyrophosphate Amidotransferase (PPAT) with Antifolate Inhibitors
, 2019; 19(5): 408-416.Nousheen Bibi*, Zahida Parveen, Muhammad Sulaman Nawaz and Mohammad Amjad Kamal
DOI: 10.2174/1568009619666181127115015
Targeting Glycosylation Aberrations to Improve the Efficiency of Cancer Phototherapy
, 2019; 19(5): 349-359.Guillaume Poiroux, Annick Barre, Pierre Rougé and Hervé Benoist*
DOI: 10.2174/1568009618666180628101059
Blocking IL-6/GP130 Signaling Inhibits Cell Viability/Proliferation, Glycolysis, and Colony Forming Activity in Human Pancreatic Cancer Cells
, 2019; 19(5): 417-427.Xiang Chen, Jilai Tian, Gloria H. Su and Jiayuh Lin*
DOI: 10.2174/1568009618666180430123939
The Multifunctional Protein p62 and Its Mechanistic Roles in Cancers
, 2019; 19(6): 468-478.Shunbin Ning and Ling Wang*
DOI: 10.2174/1568009618666181016164920
Characterization of YY1 OPB Peptide for its Anticancer Activity
, 2019; 19(6): 504-511.Yige Qi, Ting Yan, Lu Chen, Qiang Zhang, Weishu Wang, Xu Han, Dangdang Li, Jinming Shi and Guangchao Sui*
DOI: 10.2174/1568009618666181031153151
Mesoporous Silica Nanoparticles as a Prospective and Promising Approach for Drug Delivery and Biomedical Applications
, 2019; 19(4): 285-295.Xiaohui Pu, Jia Li, Peng Qiao, Mengmeng Li, Haiyan Wang, Lanlan Zong*, Qi Yuan and Shaofeng Duan*
DOI: 10.2174/1568009619666181206114904
  |
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net